Evidence map›Paper›PMID 33451188›Full record

ArticleIET systems biology2018

Optimal neuro-fuzzy control of hepatitis C virus integrated by genetic algorithm.

Javad Khodaei-Mehr, Samaneh Tangestanizadeh, Ramin Vatankhah, Mojtaba Sharifi

Abstract read
In one paragraph

Article in IET systems biology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Javad Khodaei-MehrSchool of Mechanical Engineering, Shiraz University, Molla-sadra Street, Shiraz, Iran.
Samaneh TangestanizadehSchool of Mechanical Engineering, Shiraz University, Molla-sadra Street, Shiraz, Iran.
Ramin VatankhahSchool of Mechanical Engineering, Shiraz University, Molla-sadra Street, Shiraz, Iran.
Mojtaba SharifiSchool of Mechanical Engineering, Shiraz University, Molla-sadra Street, Shiraz, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hepatitis C blood born virus is a major cause of liver disease that more than three per cent of people in the world is dealing with, and the spread of hepatitis C virus (HCV) infection in different populations is one of the most important issues in epidemiology. In the present study, a new intelligent controller is developed and tested to control the hepatitis C infection in the population which the authors refer to as an optimal adaptive neuro-fuzzy controller. To design the controller, some data is required for training the employed adaptive neuro-fuzzy inference system (ANFIS) which is selected by the genetic algorithm. Using this algorithm, the best control signal for each state condition is chosen in order to minimise an objective function. Then, the prepared data is utilised to build and train the Takagi-Sugeno fuzzy structure of the ANFIS and this structure is used as the controller. Simulation results show that there is a significant decrease in the number of acute-infected individuals by employing the proposed control method in comparison with the case of no intervention. Moreover, the authors proposed method improves the value of the objective function by 19% compared with the ordinary optimal control methods used previously for HCV epidemic.

Indexed as

acute-infected individualsadaptive controladaptive neuro-fuzzy inference systemANFISbloodcontrol signaldiseasesepidemicsepidemiologyfuzzy controlgenetic algorithmgenetic algorithmsHCV epidemichepatitis C blood born virushepatitis C virus infectionintelligent controllerliver diseasemedical computingmedical control systemsmicroorganismsneurocontrollersobjective function minimisationoptimal adaptive neuro-fuzzy controllerordinary optimal control methodsstate conditionTakagi-Sugeno fuzzy structure

Identifiers

PMID33451188
PMCPMC8687377

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.